title: [Correction of immunologic disorders in patients with chronic suppurative otitis media].
abstract: The absolute and relative content of T- and B-lymphocytes, T-helpers (CD4), T-suppressors (CD8), phagocytosis, complement and immunoglobulins A, M, G in the blood serum was examined in patients with chronic purulent otitis media. The investigation also involved tests on immunological activity of tymoptin (T), sodium nucleinate (SN), prodigiosan (PR), the combination of SN with PR. 148 patients aged 15-56 years were subdivided into 5 groups. In pretreatment immunological status of all the patients the count of T- and B-lymphocytes, T-helpers, phagocytosis were reduced against increased counts of IgM and T-suppressora. All the patients received similar conventional treatment with adjuvant SN (group 2), PR (group III), SN + PR (group 4), T (group 5). The conventional conservative and especially surgical treatment aggravated immunodeficiency. The adjuvant immunocorrectors potentiated the treatment effects which appeared to be most beneficial in group V followed by by groups IV, II and III in diminishing order.
authors.forename: S A
authors.initials: SA
authors.lastname: Iarlykov
authors.forename: S D
authors.initials: SD
authors.lastname: Poliakova
authors.forename: A M
authors.initials: AM
authors.lastname: Zemskov
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology; D002908:Chronic Disease; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D008297:Male; D008875:Middle Aged; D009696:Nucleic Acids / Q000627:therapeutic use*; D010035:Otitis Media, Suppurative / Q000097:blood / Q000276:immunology / Q000628:therapy*; D010586:Phagocytes / Q000276:immunology; D011354:Prodigiozan / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology; D013947:Thymosin / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000276:Adjuvants, Immunologic; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D009696:Nucleic Acids; C065652:timoptin; D013947:Thymosin; C013683:sodium nucleinate; D011354:Prodigiozan
vernacular_title: Korrektsiia immunologicheskikh narusheniĭ u bolńykh khronicheskim gnoĭnym srednim otitom.